Ningbo Menovo Pharmaceutical Co., Ltd.
603538.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$9.67B
Close$
Share Statistics
| Market cap | $9.67 Billion |
|---|---|
| Enterprise Value | $10.25 Billion |
| Dividend Yield | $0.15 (0.54%) |
| Earnings per Share | $0.48 |
| Beta | -0.05 |
| Outstanding Shares | 271,058,967 |
Return
| Return on Equity | 3.99% |
|---|---|
| Return on Assets | 2.47% |
| Return on Invested Capital | 5.61% |
Valuation & Multiples
| P/E Ratio | 58.19 |
|---|---|
| PEG | 345.08 |
| Price to Sales | 4.03 |
| Price to Book Ratio | 2.2 |
| Enterprise Value to Revenue | 6.09 |
| Enterprise Value to EBIT | 56.92 |
| Enterprise Value to Net Income | 87 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.36 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
October 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Ningbo Menovo Pharmaceutical Co., Ltd.
2,370 employees
CEO: Cheng Zhi Yao Ningbo Menovo Pharmaceutical Co., Ltd. operates across the full spectrum of pharmaceutical activities, encompassing the research, development, production, and distribution of medicinal products. Their extensive product line features Acti...